18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer’s Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer’s Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume -, Issue -, Pages 1-11
Publisher
IOS Press
Online
2019-07-16
DOI
10.3233/jad-190220
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding the Amyloid Hypothesis in Alzheimer’s Disease
- (2019) Giulia Paroni et al. JOURNAL OF ALZHEIMERS DISEASE
- A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer’s Disease
- (2018) Enrico R. Fantoni et al. JOURNAL OF ALZHEIMERS DISEASE
- Circular Inference in Dementia Diagnostics
- (2018) Poul F. Høilund-Carlsen et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review
- (2018) Vladimir Kepe et al. JOURNAL OF ALZHEIMERS DISEASE
- Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
- (2018) Andrew J. Aschenbrenner et al. NEUROLOGY
- Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET
- (2017) Matthias Brendel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The diagnostic value of FDG and amyloid PET in Alzheimer’s disease—A systematic review
- (2017) Louise Rice et al. EUROPEAN JOURNAL OF RADIOLOGY
- Alzheimer’s Disease Biomarkers and Future Decline in Cognitive Normal Older Adults
- (2017) Julien Dumurgier et al. JOURNAL OF ALZHEIMERS DISEASE
- β-amyloid PET neuroimaging: A review of radiopharmaceutical development
- (2017) A.-C. Dupont et al. Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique
- Deaths from Alzheimer’s Disease — United States, 1999–2014
- (2017) Christopher A. Taylor et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Novel assessment of global metabolism by 18F-FDG-PET for localizing affected lobe in temporal lobe epilepsy
- (2016) Jonah Peter et al. NUCLEAR MEDICINE COMMUNICATIONS
- Regional brain hypometabolism is unrelated to regional amyloid plaque burden
- (2015) Andre Altmann et al. BRAIN
- Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis
- (2015) Elizabeth Morris et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Amyloid Imaging in Aging and Dementia: Testing the Amyloid HypothesisIn Vivo
- (2014) G. D. Rabinovici et al. BEHAVIOURAL NEUROLOGY
- Mild cognitive impairment: a concept in evolution
- (2014) R. C. Petersen et al. JOURNAL OF INTERNAL MEDICINE
- Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
- (2013) Keith A. Johnson et al. Alzheimers & Dementia
- Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study
- (2013) Sarah Abdulla et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity
- (2013) Babak Saboury et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Amyloid deposition, hypometabolism, and longitudinal cognitive decline
- (2012) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Assessing global cardiovascular molecular calcification with 18F-fluoride PET/CT: will this become a clinical reality and a challenge to CT calcification scoring?
- (2012) Sandip Basu et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET
- (2012) Rik Ossenkoppele et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
- (2012) David A Wolk et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Initial Clinical Comparison of 18F-Florbetapir and 18F-FDG PET in Patients with Alzheimer Disease and Controls
- (2012) A. B. Newberg et al. JOURNAL OF NUCLEAR MEDICINE
- Amyloid- Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods
- (2012) S. M. Landau et al. JOURNAL OF NUCLEAR MEDICINE
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- Brain Amyloid Imaging — FDA Approval of Florbetapir F18 Injection
- (2012) Lucie Yang et al. NEW ENGLAND JOURNAL OF MEDICINE
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease
- (2011) Bradley T. Hyman ARCHIVES OF NEUROLOGY
- Amyloid-β imaging with PET in Alzheimer’s disease: is it feasible with current radiotracers and technologies?
- (2011) Mateen C. Moghbel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
- (2011) Kerryn E. Pike et al. NEUROPSYCHOLOGIA
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
- (2010) D. F. Wong et al. JOURNAL OF NUCLEAR MEDICINE
- Amyloid imaging in mild cognitive impairment subtypes
- (2009) David A. Wolk et al. ANNALS OF NEUROLOGY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
- (2009) Jessica B.S. Langbaum et al. NEUROIMAGE
- Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies
- (2009) Juergen Dukart et al. NEUROIMAGE
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
- (2008) Howard Jay Aizenstein et al. ARCHIVES OF NEUROLOGY
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
- (2008) Clifford R. Jack et al. BRAIN
- Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
- (2008) L. Mosconi et al. JOURNAL OF NUCLEAR MEDICINE
- PET imaging of amyloid deposition in patients with mild cognitive impairment
- (2007) Anton Forsberg et al. NEUROBIOLOGY OF AGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search